BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 33839323)

  • 1. The evolving landscape of N
    Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
    Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk among m
    Zhang F; Liu H; Duan M; Wang G; Zhang Z; Wang Y; Qian Y; Yang Z; Jiang X
    J Hematol Oncol; 2022 Jul; 15(1):84. PubMed ID: 35794625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA methylations in human cancers.
    Han X; Wang M; Zhao YL; Yang Y; Yang YG
    Semin Cancer Biol; 2021 Oct; 75():97-115. PubMed ID: 33220459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
    Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S
    Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis: a critical mechanism of N
    Wei Q; Xue C; Li M; Wei J; Zheng L; Chen S; Duan Y; Deng H; Tang F; Xiong W; Zhou M
    Sci China Life Sci; 2024 Jun; 67(6):1119-1132. PubMed ID: 38811442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N
    Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
    Front Immunol; 2021; 12():697026. PubMed ID: 34526985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of N6-methyladenosine mRNA in the tumor microenvironment.
    Li M; Zha X; Wang S
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188522. PubMed ID: 33545295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between N
    Chen Y; Lin Y; Shu Y; He J; Gao W
    Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA N
    Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
    Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylases in tumors and the tumor microenvironment: Key modifiers of N
    Guo J; Zhao L; Duan M; Yang Z; Zhao H; Liu B; Wang Y; Deng L; Wang C; Jiang X; Jiang X
    Biomed Pharmacother; 2024 May; 174():116479. PubMed ID: 38537580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Sun M; Xie M; Zhang T; Wang Y; Huang W; Xia L
    Front Immunol; 2021; 12():739768. PubMed ID: 34616403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of m
    Wu X; Bai Z
    Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.